Burnham & Co’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36M Sell
12,828
-75
-0.6% -$19.2K 2.65% 13
2026
Q2
$3.25M Sell
12,903
-100
-0.8% -$21.5K 2.62% 13
2026
Q1
$2.83M Buy
+13,003
New +$2.88M 2.68% 11

Other funds holding ABBV

Burnham & Co's ABBV Position: Q3 2026 in Review

Burnham & Co reduced its AbbVie (ABBV) stake by 0.58% in Q3 2026, selling an estimated $19.2K and leaving 12,828 shares worth $3.36M. The position accounts for 2.65% of the portfolio, ranked #13.

Burnham & Co first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Burnham & Co held 12,828 shares of AbbVie worth $3.36M as of Q3 2026.
  • Burnham & Co sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
  • AbbVie made up 2.65% of Burnham & Co's portfolio in Q3 2026, its #13 holding.
  • Burnham & Co first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.